Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability

Annals of Hematology

Volumn 92, Issue 10, 2013, Pages 1325-1333

  Nolte, Florian ^a   Giehl, Michelle ^a   Haass, Wiltrud ^a   Nowak, Verena ^a   Schumann, Christiane ^a   Nowak, Daniel ^a   Mossner, Maximillian ^a   Popp, Henning D ^a   Schulze, Torsten J ^b   Klein, Stefan ^a   Seifarth, Wolfgang ^a   Hofmann, Wolf Karsten ^a   Fabarius, Alice ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Centrosomes; Genetic instability; Karyotype; Myelodysplastic syndrome; Separase

Indexed keywords

PERICENTRIN ANTIBODY; PROTEIN ANTIBODY; SEPARASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CENTROSOME; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC STABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

AGED; BONE MARROW CELLS; CENTROSOME; CHROMOSOMAL INSTABILITY; FEMALE; HUMANS; KARYOTYPE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 84883862595     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1772-7     Document Type: Article

References (41)

1. Haase D, Feuring-Buske M, Schäfer C, Schoch C, Troff C et al (1997) Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117. Leukemia 11:674-679
2. Valent P, Horny HP, Bennett JM, Fonatsch C, Germing U et al (2007) Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 31:727-736
3. Mitelman F, Johansson B, Mertens F. Mitelman Database of chromosome aberrations in cancer http://cgap.nci.nih.gov/chromosomes/mitelman
4. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088
5. Haase D, Germing U, Schanz J, Pfeilstöcker M, Nösslinger T et al (2007) New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 110:4385-4395
6. Schanz J, Tüchler H, Solé F, Mallo M, Luño E et al (2012) New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol 30:820-829
7. Bettencourt-Dias M, Glover DM (2007) Centrosome biogenesis and function: centrosomics brings new understanding. Nat Rev Mol Cell Biol 8:451-463
8. Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L et al (2001) Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 61:2212-2219
9. Krämer A, Schweizer S, Neben K, Giesecke C, Kalla J et al (2003) Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma. Leukemia 17:2207-2213
10. Pihan GA, Wallace J, Zhou Y, Doxsey SJ (2003) Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63:1398-1404
11. Neben K, Giesecke C, Schweizer S, Ho AD, Krämer A (2003) Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile. Blood 101:289-291
12. Schneeweiss A, Sinn HP, Ehemann V, Khbeis T, Neben K et al (2003) Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int J Cancer 107:346-352
13. Giehl M, Fabarius A, Frank O, Hochhaus A, Hafner M et al (2005) Centrosome aberrations in chronic myeloid leukemia correlate with disease progression and chromosomal instability. Leukemia 19:1192-1197
14. Yamamoto Y, Eguchi S, Junpei A, Nagao K, Sakano S et al (2009) Intercellular centrosome number is correlated with the copy number of chromosomes in bladder cancer. Cancer Genet Cytogenet 191:38-42
15. Chan JY (2011) A clinical overview of centrosome amplification in human cancers. Int J Biol Sci 7:1122-1144
16. Brinkley BR (2001) Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11:18-21
17. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW (2007) Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11:25-36
18. Nigg EA (2007) Centrosome duplication: of rules and licenses. Trends Cell Biol 17:215-221
19. Zhang N, Ge G, Meyer R, Sethi S, Basu D et al (2008) Overexpression of separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A 105:13033-13038
20. Meyer R, Fofanov V, Panigrahi A, Merchant F, Zhang N et al (2009) Overexpression and mislocalization of the chromosomal segregation protein separase in multiple human cancers. Clin Cancer Res 15:2703-2710
21. Patel H, Gordon MY (2009) Abnormal centrosome-centriole cycle in chronic myeloid leukaemia? Br J Haematol 146:408-417
22. Xu J, Wang M, Gao X, Hu B, Du Y et al (2011) Separase phosphosite mutation leads to genome instability and primordial germ cell depletion during oogenesis. PLoS One 6:e18763
23. Mossner M, Nolte F, Hütter G, Reins J, Klaumünzer M, Nowak V et al (2012) Skewed X-inactivation patterns in ageing healthy and myelodysplastic haematopoiesis determined by a pyrosequencing based transcriptional clonality assay. J Med Genet 50:108-117
24. Giehl M, Leitner A, Haferlach C, Duesberg P, Hofmann WK, Hofheinz R et al (2010) Detection of centrosome aberrations in disease-unrelated cells from patients with tumor treated with tyrosine kinase inhibitors. Eur J Haematol 85:139-148
25. Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus A et al (2002) Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia 16:53-59
26. Shaffer L, Slovak M, Campbell L eds. ISCN (2009) An international system for human cytogenetic nomenclature, Basel: Karger
27. Testoni N, Marzocchi G, Luatti S, Amabile M, Baldazzi C et al (2009) Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP. Blood 114:4939-4943
28. Fabarius A, Giehl M, Frank O, Duesberg P, Hochhaus A et al (2005) Induction of centrosome and chromosome aberrations by imatinib in vitro. Leukemia 19:1573-1578
29. Fabarius A, Giehl M, Frank O, Spiess B, Zheng C et al (2007) Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with spindle defects and genetic instability. Br J Haematol 138:369-373
30. Giehl M, Fabarius A, Frank O, Erben P, Zheng C et al (2007) Expression of the p210BCR-ABL oncoprotein drives centrosomal hypertrophy and clonal evolution in human U937 cells. Leukemia 21:1971-1976
31. Fabarius A, Giehl M, Rebacz B, Krämer A, Frank O et al (2008) Centrosome aberrations and G1 phase arrest after in vitro and in vivo treatment with the SRC/ABL inhibitor dasatinib. Haematologica 93:1145-1154
32. Haaß W, Stehle M, Nittka S, Giehl M, Schrotz-King P et al. (2012) The proteolytic activity of separase in BCR-ABL-positive cells is increased by imatinib. PLoS One e42863. Epub 2012 Aug 3
33. Schvartzman JM, Sotillo R, Benezra R (2010) Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 10:102-115
34. Waizenegger I, Giménez-Abián JF, Wernic D, Peters JM (2002) Regulation of human separase by securin binding and autocleavage. Curr Biol 12:1368-1378
35. Giménez-Abián JF, Díaz-Martínez LA, Waizenegger IC, Giménez-Martín G, Clarke DJ (2005) Separase is required at multiple pre-anaphase cell cycle stages in human cells. Cell Cycle 4:1576-1584
36. Pandey R, Heidmann S, Lehner CF (2005) Epithelial re-organization and dynamics of progression through mitosis in Drosophila separase complex mutants. J Cell Sci 118:733-742
37. Kumada K, Yao R, Kawaguchi T, Karasawa M, Hoshikawa Y et al (2006) The selective continued linkage of centromeres from mitosis to interphase in the absence of mammalian separase. J Cell Biol 172:835-846
38. Shepard JL, Amatruda JF, Finkelstein D, Ziai J, Finley KR et al (2007) A mutation in separase causes genome instability and increased susceptibility to epithelial cancer. Genes Dev 21:55-59
39. Fukasawa K (2007) Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 7:911-924
40. Baker DJ, Jin F, Jeganathan KB, van Deursen JM (2009) Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 16:475-486
41. Kearns WG, Yamaguchi H, Young NS, Liu JM (2004) Centrosome amplification and aneuploidy in bone marrow failure patients. Genes Chromosomes Cancer 40:329-333